PPARA and metabolic dysfunction-associated steatotic liver disease: Hyodeoxycholic acid (HDCA) improves NAFLD via PPARα activation, inhibits abnormal nuclear–cytoplasmic shuttling, and reduces lipid accumulation and oxidative stress (Zhong et al., 2023).